Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
13
Number of overlapping holdings
31.7%
% of GNOM's 41 holdings also in XDNA
56.5%
% of XDNA's 23 holdings also in GNOM
Overlap by Weight
Sector Drift (GNOM minus XDNA)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
Company | Weight in GNOM |
Weight in XDNA |
Overlap | |
---|---|---|---|---|
CRISPR THERAPEUTICS AG | 5.5% | 15.1% | 5.5% | |
BEAM THERAPEUTICS, INC. | 3.8% | 13.7% | 3.8% | |
INTELLIA THERAPEUTICS, INC. | 3.3% | 8.7% | 3.3% | |
AGILENT TECHNOLOGIES INC | 4.3% | 2.7% | 2.7% | |
VERTEX PHARMACEUTICALS INC | 1.7% | 1.5% | 1.5% |
Position Highlights (Non-Overlapping Exposures)
GNOM Overweight Relative to XDNA
NATERA INC | 6.9% | |
ENI SPA-SPONSORED ADR | 6.3% | |
ULTRAGENYX PHARMACEUTICAL IN | 4.2% | |
MODERNA, INC. | 4.1% | |
SAREPTA THERAPEUTICS INC | 3.6% | |
BIO-TECHNE CORPORATION | 3.5% | |
ROCKET PHARMACEUTICALS, INC. | 3.4% | |
ARROWHEAD PHARMACEUTICALS, INC. | 3.4% | |
BIOMARIN PHARMACEUTICAL INC | 3.1% | |
MYRIAD GENETICS INC | 2.9% |
GNOM Underweight Relative to XDNA
BEAM THERAPEUTICS, INC. | -9.9% | |
CRISPR THERAPEUTICS AG | -9.7% | |
THERMO FISHER SCIENTIFIC INC | -9.5% | |
PRIME MEDICINE, INC. | -5.9% | |
INTELLIA THERAPEUTICS, INC. | -5.4% | |
EDITAS MEDICINE, INC. | -4.7% | |
CARIBOU BIOSCIENCES, INC. | -4.0% | |
ABBVIE INC | -3.8% | |
POSEIDA THERAPEUTICS, INC. | -3.7% | |
VERVE THERAPEUTICS, INC. | -3.6% |